InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Cravatt Benjamin, Director. Officer active across 1 company, notably FIBROGEN INC. Cumulatively, 4 disclosures have been published. History available since 26 May 2021. The latest transaction was filed on 7 June 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
8,289 shares0Common StockSEC:0001209191-23-036081:0
15,777 shares0Common StockSEC:0001209191-22-038606:0
4,700 shares0Common StockSEC:0001209191-21-036671:0
4,700 shares0Common StockSEC:0001209191-21-036671
4 of 4 declarations
About Cravatt Benjamin
Benjamin Cravatt is a Board Member at FibroGen Inc. He brings expertise in biotechnology and corporate governance. In his role, Cravatt is involved in making strategic decisions that influence the company's direction.
